Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wheat gluten hydrolysate is a mixture of bioactive peptides and amino acids produced through the enzymatic hydrolysis of wheat gluten. It is distinguished by an exceptionally high concentration of L-glutamine, typically comprising approximately 30% of its total amino acid profile. In the fields of sports nutrition and clinical health, it is utilized to support muscle protein synthesis, accelerate recovery following strenuous exercise, and maintain intestinal barrier integrity. Beyond its nutritional value, wheat gluten hydrolysate has been studied for its potential therapeutic effects, including the inhibition of Angiotensin-Converting Enzyme (ACE) and Dipeptidyl Peptidase 4 (DPP4), which suggest applications in managing hypertension and glycemic control. It is primarily manufactured by food science and ingredient companies as a highly soluble and absorbable alternative to intact wheat protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wheat gluten hydrolysate.